Delivery Order SPE2DX15D3018-SPE2DX24F9VB4
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML. The contract has a ceiling value of $12,972.80 and a period of performance through August 12, 2024. This award is not set aside for any specific business category. AmerisourceBergen, a major pharmaceutical distributor, holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML medical products. The contract has a ceiling value of $46,047.92 and an ultimate completion date of January 11, 2024. The contract is a firm-fixed-price delivery order, with no set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML, a pharmaceutical product, with a ceiling value of $10,063.66. The contract has an ultimate completion date of January 25, 2024 and is a firm fixed-price delivery order. This award is not associated with a set-aside program....
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp for the supply of the pharmaceutical product VAXNEUVANCE 0.5 ML SYRINGE 0.5ML. The contract has a ceiling value of $9,281.61 and is a firm fixed price delivery order with a final completion date of July 26, 2024. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is the prime contractor with no set-aside designation. This contract is likely part of...
- This is a firm-fixed price delivery order contract awarded by the Defense Logistics Agency's (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, Corporate Office Division. The contract is for the supply of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML, a pharmaceutical product, and has a ceiling value of $25,131.35. The contract has an ultimate completion date of September 9, 2024. AmerisourceBergen, a major pharmaceutical distributor, provides a wide range of medical supplies and prescription...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $41,577.47, is for the supply of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML medical products. The contract has a firm fixed price pricing type and an ultimate completion date of January 17, 2025. AmerisourceBergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC)...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $13,767.01 and is for the delivery of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML, a medical product. The contract is a firm fixed-price delivery order with an ultimate completion date of April 2, 2025. This contract is not designated as a set-aside. AmerisourceBergen Drug Corp...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $36,222.54 firm fixed-price contract is for the supply of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of December 10, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,060.51, is for the supply of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML, a pharmaceutical product. The contract is a firm fixed-price delivery order with an ultimate completion date of April 11, 2025. Amerisourcebergen Drug Corp is the prime contractor, and the contract is not set aside. The...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML, a medical product, with a ceiling value of $19,840.50 and a period of performance through January 9, 2024. The contract is a firm-fixed-price delivery order, which is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen...
- SPE2DX15D3018Indefinite Delivery Contract
- SPE2DX15D3018-SPE2DX24F9VB4Delivery Order
This is a delivery order contract awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical for the supply of the VAXNEUVANCE 0.5 ML SYRINGE 0.5ML medical product. The contract has a ceiling value of $12,734.82 and a completion date of November 21, 2023. The contract is a firm fixed-price delivery order, with no set-aside designation noted. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that maintains several Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC with the DLA Troop Support Medical and a $750,000 IDC with the Department of Justice Federal Bureau of Investigation, to supply a comprehensive range of pharmaceutical products and medical supplies to support military, veterans, and other federal healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.7k | 11/20/23 |